Volitionrx (VNRX) Debt to Equity (2019 - 2025)
Historic Debt to Equity for Volitionrx (VNRX) over the last 8 years, with Q3 2025 value amounting to -$0.18.
- Volitionrx's Debt to Equity rose 1504.11% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year increase of 1504.11%. This contributed to the annual value of -$0.18 for FY2024, which is 6675.96% up from last year.
- Latest data reveals that Volitionrx reported Debt to Equity of -$0.18 as of Q3 2025, which was up 1504.11% from -$0.21 recorded in Q2 2025.
- In the past 5 years, Volitionrx's Debt to Equity registered a high of $1.18 during Q3 2022, and its lowest value of -$1.23 during Q1 2023.
- Over the past 5 years, Volitionrx's median Debt to Equity value was -$0.19 (recorded in 2024), while the average stood at -$0.14.
- Over the last 5 years, Volitionrx's Debt to Equity had its largest YoY gain of 79994.44% in 2022, and its largest YoY loss of 81031.64% in 2022.
- Quarter analysis of 5 years shows Volitionrx's Debt to Equity stood at $0.17 in 2021, then tumbled by 810.32% to -$1.23 in 2022, then skyrocketed by 54.91% to -$0.55 in 2023, then skyrocketed by 66.76% to -$0.18 in 2024, then grew by 2.23% to -$0.18 in 2025.
- Its Debt to Equity stands at -$0.18 for Q3 2025, versus -$0.21 for Q2 2025 and -$0.22 for Q1 2025.